Eko Appoints Dr. Adam Saltman as Chief Medical Officer
OAKLAND, Calif.--(BUSINESS WIRE)--Apr 14, 2020--
Eko today announced the appointment of Adam Saltman, M.D., Ph.D., to the position of Chief Medical Officer (CMO). Dr. Saltman will assume responsibility for leading Eko’s overall clinical development and medical affairs activities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200414005128/en/
Dr. Adam Saltman, Chief Medical Officer, Eko (Photo: Business Wire)
“Adam brings a wealth of experience across disciplines in cardiology and pulmonology, as well as from government and academic sectors. Adam will help advance our bold clinical vision for prevalent conditions such as heart failure and chronic respiratory diseases,” said Connor Landgraf, co-founder and CEO of Eko. “At this challenging time in healthcare, Adam will be instrumental in helping us build technology to improve how care is provided. We welcome Adam’s leadership and expertise as we continue to grow Eko.”
Dr. Saltman joins the Eko executive team from the U.S. Food and Drug Administration (FDA). As a medical officer at the Center for Devices and Radiological Health, he was awarded for his leadership of multiple programs related to medical devices. While at the FDA, he co-wrote a whitepaper outlining a new regulatory approach to AI and machine learning algorithms, which play a key role in Eko’s clinical vision. Prior to joining the FDA in 2013, he practiced as a triple-board certified cardiothoracic surgeon at various hospitals including Mount Sinai Beth Israel and the University of Massachusetts.
“In this new role, I’m able to combine my passion for helping patients with being a part of a leadership team that is developing the next evolution in digital health solutions in cardiopulmonary care and is truly making a difference in the future of telehealth medicine,” said Dr. Saltman. “I’m proud to play a part in growing Eko and advancing our technologies.”
Dr. Saltman received his M.D. and Ph.D. degrees in electrophysiology from Columbia University, in addition to an M.S. in health informatics from the University of Illinois at Chicago and a B.A. in biochemistry from Harvard University. Dr. Saltman is a fellow of the American College of Surgeons, the American College of Cardiology, the American College of Chest Physicians and the American Heart Association. Published in over 100 peer-reviewed articles, Dr. Saltman has served on editorial boards, conducted competitively funded research projects, and is certified as a Quality Improvement Associate by the American Society for Quality.
Eko is driving the next evolution in cardiac and pulmonary care by creating digital health solutions that enable doctors, nurses and entire health systems to change how we care for the heart. Eko brings together advanced stethoscopes, patient and provider software, and AI-powered analysis—elevating the way clinicians detect and monitor cardiovascular and respiratory disease. Its FDA cleared platform is used by thousands of clinicians treating tens of millions of patients around the world. Eko is a privately-held and headquartered in Oakland, California. For more information visit www.ekohealth.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200414005128/en/
+1 (781) 235-3060
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: TECHNOLOGY MEDICAL DEVICES OTHER TECHNOLOGY CARDIOLOGY BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL GENERAL HEALTH
Copyright Business Wire 2020.
PUB: 04/14/2020 08:00 AM/DISC: 04/14/2020 08:00 AM